Development of a Direct Alhydrogel Formulation Immunoassay (DAFIA)

Journal of Immunological Methods

Volumn 344, Issue 1, 2009, Pages 73-78

  Zhu, Daming ^a   Huang, Shuhui ^a   Gebregeorgis, Elizabeth ^a   McClellan, Holly ^a   Dai, Weili ^a   Miller, Louis ^a   Saul, Allan ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Alhydrogel; Antigen content; DAFIA; Plasmodium falciparum apical membrane antigen 1; Vaccine

Indexed keywords

ALUMINUM HYDROXIDE; APICAL MEMBRANE ANTIGEN 1;

ACCURACY; ANTIGEN SPECIFICITY; ARTICLE; DIRECT ALHYDROGEL FORMULATION IMMUNOASSAY; DRUG DETERMINATION; DRUG FORMULATION; DRUG QUALITY; IMMUNOASSAY; MODEL; PRIORITY JOURNAL; QUALITY CONTROL; WESTERN BLOTTING;

ALUMINUM HYDROXIDE; ANIMALS; ANTIGENS; ANTIGENS, PROTOZOAN; IMMUNOASSAY; MEMBRANE PROTEINS; O-PHTHALALDEHYDE; PROTOZOAN PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

PLASMODIUM FALCIPARUM;

EID: 65049091202     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2009.03.005     Document Type: Article

References (17)

1. Baylor N.W., Egan W., and Richman P. Aluminum salts in vaccines-US perspective. Vaccine 31;20 Suppl 3 (2002) S18
2. Church F.C., Porter D.H., Catignani G.L., and Swaisgood H.E. An o-phthalaldehyde spectrophotometric assay for proteinases. Anal. Biochem. 1;146 2 (1985) 343
3. Gupta R.K. Aluminum compounds as vaccine adjuvants. Adv. Drug Deliv. Rev. 6;32 3 (1998) 155
4. Hem S.L., and Hogenesch H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev. Vaccines 6 5 (2007) 685
5. Johnston C.T., Wang S.L., and Hem S.L. Measuring the surface area of aluminum hydroxide adjuvant. J. Pharm. Sci. 91 7 (2002) 1702
6. Kato K., Mayer D.C., Singh S., Reid M., and Miller L.H. Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx. Proc. Natl. Acad. Sci. U. S. A. 102 15 (2005) 5552
7. Katz J. Desorption of porcine parvovirus from aluminum hydroxide adjuvant with subsequent viral immunoassay or hemagglutination assay. Vet. Res. Commun. 11 1 (1987) 83
8. Kennedy M.C., et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect. Immun. 70 12 (2002) 6948
9. Lindblad E.B. Aluminium compounds for use in vaccines. Immunol. Cell Biol. 82 5 (2004) 497
10. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 9;22 27-28 (2004) 3658 Review
11. Morefield G.L., HogenEsch H., Robinson J.P., and Hem S.L. Distribution of adsorbed antigen in mono-valent and combination vaccines. Vaccine 7;22 15-16 (2004) 1973
12. Peek L.J., Martin T.T., Elk Nation C., Pegram S.A., and Middaugh C.R. Effects of stabilizers on the destabilization of proteins upon adsorption to aluminum salt adjuvants. J. Pharm. Sci. 96 3 (2007) 547
13. Porter D.H., Swaisgood H.E., and Catignani G.L. A rapid fluorometric assay for measurement of peptidase activity. Anal. Biochem. 123 1 (1982) 41
14. Remarque E.J., Faber B.W., Kocken C.H., and Thomas A.W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 24 2 (2008) 74 Review
15. Roth M. Fluorescence reaction for amino acids. Anal. Chem. 43 7 (1971) 880
16. Singh M., and O'Hagan D.T. Recent advances in vaccine adjuvants. Pharm. Res. 19 6 (2002) 715
17. World Health Organization. Technical Report Series No. 595 (1976) 6